Search

Meeting Coverage:

Caribbean Eye

Caribbean Eye: 2016

Updates With Rho Kinase

Jason Bacharach, MD, Robert Weinstock, MD

Show Description +

Jason Bacharach, MD, speaks with Robert Weinstock, MD, about rho kinase inhibitors as the first new class of glaucoma agents in over two decades that can be used for the management of disease. The new mechanism of action diverts fluid away from the trabecular meshwork through the uveoscleral system or by reducing aqueous production through beta blockers. Dr. Bacharach points out that the new drug works very well at low starting pressures.

Posted: 1/31/2016

Up Next

Identifying the Cause of Dry Eye

Identifying the Cause of Dry Eye

Alan Carlson, MD, Robert Weinstock, MD

Cultivating a Positive Culture in a Practice

Cultivating a Positive Culture in a Practice

Craig N. Piso, PhD, David W. Evans, PhD

Swimming in the Presbyopia Patient Pool

Swimming in the Presbyopia Patient Pool

Darrell White, MD, Keith Walter, MD

Getting CheckedUp On Patient Education

Getting CheckedUp On Patient Education

Cynthia Matossian, MD

The Laser's Effect on YAG Rates

The Laser's Effect on YAG Rates

Dan B. Tran, MD, P. Dee Stephenson, MD

Presbyopia Utopia: Current and Upcoming Treatments

Presbyopia Utopia: Current and Upcoming Treatments

Mark Kontos, MD, Steven Dell, MD

“They're Cooler Than Me”: Expectations of Today's LASIK Patients

“They're Cooler Than Me”: Expectations of Today's LASIK Patients

Darrell E. White, MD, James Loden, MD

Taking it Up a Notch: New Software for Femto

Taking it Up a Notch: New Software for Femto

Alan Carlson, MD, Robert J. Weinstock, MD

In Vitro Results With Automated Anterior Capsulotomies

In Vitro Results With Automated Anterior Capsulotomies

P. Dee G. Stephenson, MD, FACS, Sumitra S. Khandelwal, MD

Dress Your Best: Online Images Count

Dress Your Best: Online Images Count

Craig N. Piso, PhD, David W. Evans, PhD

Scleral Implants for the Correction of Presbyopia

Scleral Implants for the Correction of Presbyopia

Sumitra S. Khandelwal, MD, Y. Ralph Chu, MD

Updates With Rho Kinase

Updates With Rho Kinase

Jason Bacharach, MD, Robert Weinstock, MD

Back to All Videos

Updates With Rho Kinase

Jason Bacharach, MD, Robert Weinstock, MD

Jason Bacharach, MD, speaks with Robert Weinstock, MD, about rho kinase inhibitors as the first new class of glaucoma agents in over two decades that can be used for the management of disease. The new mechanism of action diverts fluid away from the trabecular meshwork through the uveoscleral system or by reducing aqueous production through beta blockers. Dr. Bacharach points out that the new drug works very well at low starting pressures.

Posted: 1/31/2016

Please log in to leave a comment.

More From Caribbean Eye: 2016 Coverage

Identifying the Cause of Dry Eye

Identifying the Cause of Dry Eye

Alan Carlson, MD, Robert Weinstock, MD

Cultivating a Positive Culture in a Practice

Cultivating a Positive Culture in a Practice

Craig N. Piso, PhD, David W. Evans, PhD

Swimming in the Presbyopia Patient Pool

Swimming in the Presbyopia Patient Pool

Darrell White, MD, Keith Walter, MD

Getting CheckedUp On Patient Education

Getting CheckedUp On Patient Education

Cynthia Matossian, MD